Paroxetine Tablet, Film Coated, Extended Release
Product Images NDC 72241-029

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 72241-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Modavar Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cont-label-12-5mg-30-tab (Cont Label 12 5mg 30 Tab)

Label for Paroxetine Extended-Release Tablets, 12.5 mg film-coated, extended-release oral tablets, packaged 30 tablets per bottle. The label includes storage instructions, dosage directions, safety warnings, and packaging details. Manufactured by Cadila Pharmaceuticals Ltd. and labeled for Modavar Pharmaceuticals LLC.*

FDA Label Image

Cont-label-12-5mg-500-tab (Cont Label 12 5mg 500 Tab)

Label for Paroxetine Extended-Release Tablets 12.5 mg, film-coated, extended-release oral tablets. The label states 500 tablets per bottle and is distributed by Modavar Pharmaceuticals LLC. Includes NDC 72241-029-10 and storage instructions. Manufactured by Cadila Pharmaceuticals Ltd., India.*

FDA Label Image

Cont-label-25mg-30-tab (Cont Label 25mg 30 Tab)

Label for Paroxetine Extended-Release Tablets 25 mg by Modavar Pharmaceuticals LLC. The label states the product is an extended-release film-coated tablet containing 25 mg paroxetine. It includes storage instructions, dosage directions to refer to accompanying information, and a warning to keep tightly closed and out of reach of children. The package contains 30 tablets. Manufactured by Cadila Pharmaceuticals Ltd., India.*

FDA Label Image

Cont-label-25mg-500-tab (Cont Label 25mg 500 Tab)

Paroxetine Extended-Release Tablets 25 mg film-coated tablets label. Includes NDC 72241-030-10, packaging quantity of 500 tablets. Manufactured by Cadila Pharmaceuticals Ltd. for Modavar Pharmaceuticals LLC. The label advises dispensing the Medication Guide to each patient and indicates prescription use only.*

FDA Label Image

Cont-label-37-5mg-30-tab (Cont Label 37 5mg 30 Tab)

Label for Paroxetine Extended-Release Tablets 37.5 mg by Modavar Pharmaceuticals LLC. The label states the product is a 30-tablet package of film-coated, extended-release tablets containing 37.5 mg of paroxetine. It includes storage instructions, a barcode, manufacturer details, and a note advising pharmacists to dispense the Medication Guide to patients.*

FDA Label Image

Cont-label-37-5mg-500-tab (Cont Label 37 5mg 500 Tab)

Paroxetine Extended-Release Tablets 37.5 mg with 500 tablets per bottle. The bottle label includes dosage storage instructions, manufacturer Cadila Pharmaceuticals Ltd. and labeler Modavar Pharmaceuticals LLC information, along with a barcode and the date issued June 2021. The label indicates the product is prescription only and dispensing instructions are provided.*

FDA Label Image

Fig1 (Fig1)

A pharmacokinetic interaction graph showing fold change and 90% confidence intervals for various interacting drugs (Pimozide, Desipramine, Propranolol, Digoxin, Phenytoin) relative to a reference, with pharmacokinetic parameters Cmax and AUC indicated for each drug.*

FDA Label Image

Fig2 (Fig2)

A horizontal line chart presenting the pharmacokinetic interactions of various drugs with Paroxetine. The chart compares fold changes and 90% confidence intervals for Cmax and AUC values relative to a reference for cimetidine, phenobarbital, phenytoin, digoxin, and diazepam at specified doses and frequencies.*

FDA Label Image

Fig3 (Fig3)

A forest plot chart showing the fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, Cmin) of Paroxetine extended-release tablets in various population subgroups, including renal impairment (mild, moderate, severe), hepatic impairment, different age groups (>65 years) at multiple doses (20 mg, 30 mg, 40 mg once daily), and gender (males). The X-axis indicates change relative to reference on a logarithmic scale from 0.5 to 50.*

FDA Label Image

Paroxetine-strc-spl (Paroxetine Strc Spl)

Chemical structure of Paroxetine hydrochloride hemihydrate, showing its molecular arrangement including a fluorophenyl group, a dioxolane ring, and the hydrochloride and water components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.